IAd: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tags: mobile edit mobile web edit
 
CSV import
 
Line 1: Line 1:
'''IAd''' is an [[advertising]] platform developed by [[Apple Inc.]] for its [[iPhone]], [[iPod Touch]], and [[iPad]] line of mobile devices. It allows third-party developers to directly embed advertisements into their applications. Launched in 2010, it was discontinued in 2016.
{{short description|An overview of the International Agency for Research on Cancer (IARC)}}


== History ==
==International Agency for Research on Cancer==
[[Apple Inc.]] announced the creation of the IAd platform during an iPhone OS 4 event on April 8, 2010. The platform was part of Apple's acquisition of [[Quattro Wireless]], a mobile advertising company. IAd was launched on July 1, 2010, with a reported initial investment of $60 million from several major brands.
The '''International Agency for Research on Cancer''' (IARC) is a specialized agency of the [[World Health Organization]] (WHO) that is dedicated to conducting and coordinating research on the causes of [[cancer]]. It was established in 1965 and is headquartered in [[Lyon]], [[France]].


In January 2016, Apple announced that the IAd App Network would be discontinued as of June 30, 2016. The decision was made due to the platform's inability to compete with other online advertising platforms such as [[Google AdWords]] and [[Facebook Ads]].
[[File:IAd_Logo.png|thumb|right|The logo of the International Agency for Research on Cancer]]


== Functionality ==
==Mission and Objectives==
IAd allowed developers to incorporate a variety of advertising formats into their apps, including full-screen video ads, interactive ads, and banner ads. The platform was designed to deliver ads without users having to leave the app they were currently using.
The primary mission of IARC is to promote international collaboration in cancer research. The agency aims to:


The IAd platform also provided detailed analytics for advertisers, allowing them to track the performance of their ads and make adjustments as necessary.  
* Identify the causes of cancer.
* Elucidate the mechanisms of carcinogenesis.
* Develop scientific strategies for cancer prevention and control.


== Criticism ==
IARC conducts epidemiological and laboratory research and disseminates scientific information through publications and meetings.
Despite its innovative approach, IAd faced criticism for its high cost and low reach compared to other advertising platforms. Some advertisers also expressed dissatisfaction with Apple's control over the creative process, as the company required all ads to be designed in-house.


== See also ==
==Research Programs==
* [[Mobile advertising]]
IARC's research programs are organized into several sections and groups, each focusing on different aspects of cancer research:
* [[Online advertising]]
* [[In-app advertising]]


[[Category:Apple Inc. services]]
===Epidemiology===
[[Category:Mobile advertising services]]
The Epidemiology section studies the distribution and determinants of cancer in human populations. It aims to identify risk factors and protective factors associated with cancer.
[[Category:IOS software]]
 
{{Apple Inc.}}
===Carcinogen Identification===
{{Advertising-stub}}
IARC is well-known for its work in identifying and classifying [[carcinogens]]. The agency publishes the "IARC Monographs on the Evaluation of Carcinogenic Risks to Humans," which assess the carcinogenicity of various substances.
 
===Molecular Biology===
Research in molecular biology at IARC focuses on understanding the genetic and molecular mechanisms that lead to cancer development. This includes studies on [[DNA]] damage and repair, [[oncogenes]], and [[tumor suppressor genes]].
 
===Prevention and Implementation===
This program aims to translate research findings into effective cancer prevention strategies. It involves the development of guidelines and recommendations for reducing cancer risk.
 
==Collaborations and Partnerships==
IARC collaborates with numerous international organizations, research institutions, and governments to advance cancer research. These partnerships facilitate the sharing of data, resources, and expertise.
 
==Publications==
IARC publishes a wide range of scientific reports, monographs, and journals. These publications are essential resources for researchers, policymakers, and public health professionals worldwide.
 
==Related pages==
* [[World Health Organization]]
* [[Cancer]]
* [[Carcinogen]]
* [[Epidemiology]]
 
[[Category:World Health Organization]]
[[Category:Cancer research]]
[[Category:International organizations]]

Latest revision as of 03:32, 13 February 2025

An overview of the International Agency for Research on Cancer (IARC)


International Agency for Research on Cancer[edit]

The International Agency for Research on Cancer (IARC) is a specialized agency of the World Health Organization (WHO) that is dedicated to conducting and coordinating research on the causes of cancer. It was established in 1965 and is headquartered in Lyon, France.

The logo of the International Agency for Research on Cancer

Mission and Objectives[edit]

The primary mission of IARC is to promote international collaboration in cancer research. The agency aims to:

  • Identify the causes of cancer.
  • Elucidate the mechanisms of carcinogenesis.
  • Develop scientific strategies for cancer prevention and control.

IARC conducts epidemiological and laboratory research and disseminates scientific information through publications and meetings.

Research Programs[edit]

IARC's research programs are organized into several sections and groups, each focusing on different aspects of cancer research:

Epidemiology[edit]

The Epidemiology section studies the distribution and determinants of cancer in human populations. It aims to identify risk factors and protective factors associated with cancer.

Carcinogen Identification[edit]

IARC is well-known for its work in identifying and classifying carcinogens. The agency publishes the "IARC Monographs on the Evaluation of Carcinogenic Risks to Humans," which assess the carcinogenicity of various substances.

Molecular Biology[edit]

Research in molecular biology at IARC focuses on understanding the genetic and molecular mechanisms that lead to cancer development. This includes studies on DNA damage and repair, oncogenes, and tumor suppressor genes.

Prevention and Implementation[edit]

This program aims to translate research findings into effective cancer prevention strategies. It involves the development of guidelines and recommendations for reducing cancer risk.

Collaborations and Partnerships[edit]

IARC collaborates with numerous international organizations, research institutions, and governments to advance cancer research. These partnerships facilitate the sharing of data, resources, and expertise.

Publications[edit]

IARC publishes a wide range of scientific reports, monographs, and journals. These publications are essential resources for researchers, policymakers, and public health professionals worldwide.

Related pages[edit]